Acend Kratom Extract Tablets — 160mg Full-Spectrum Formula

The Acend Kratom Extract Tablet delivers a concentrated, full-spectrum Mitragyna speciosa extract in a convenient scored tablet made for experienced kratom consumers.

Each tablet contains 160mg of fermented kratom extract and is divided into four equal sections, allowing the tablet to be portioned into approximately 40mg of extract per quarter. The 160mg figure refers to the total weight of the kratom extract—not 160mg of mitragynine.

Rather than relying on isolated 7-hydroxymitragynine, pseudoindoxyl, or synthetic kratom analogs, Acend is positioned around a broader botanical alkaloid profile. The uploaded laboratory report found no detected 7-hydroxymitragynine or mitragynine pseudoindoxyl in the tested sample.

Scored Full-Spectrum Tablet

Each Acend tablet features:

160mg full-spectrum kratom extract
Four scored sections
Approximately 40mg extract per quarter-tablet
Mint-flavored chewable format
No detected 7-OH in the tested sample
No detected mitragynine pseudoindoxyl in the tested sample

The scored design provides more control than an unmeasured powder or liquid extract. Consumers can follow the manufacturer’s serving guidance without having to estimate portions using a scoop or dropper.

Alkaloid Profile

The April 24, 2026 Certificate of Analysis tested the tablet for six kratom alkaloids. The results show a profile dominated by speciogynine, with smaller amounts of paynantheine, mitragynine, and speciociliatine.

Speciogynine — 4.40mg/g

Speciogynine is the primary measured alkaloid in the tested tablet and accounts for the overwhelming majority of the detected alkaloid profile.

Based on the reported tablet weight of 0.518g, the result works out to approximately 2.28mg of speciogynine per tablet.

Speciogynine is a naturally occurring kratom alkaloid and a stereoisomer of mitragynine. Its presence gives Acend a distinctly different profile from a conventional high-mitragynine extract.

Paynantheine — 0.17mg/g

Paynantheine is a naturally occurring secondary alkaloid found in kratom leaf.

The reported result equals approximately 0.088mg per tablet. It contributes to the broader full-spectrum character of the extract rather than acting as the primary measured alkaloid.

Mitragynine — 0.08mg/g

Mitragynine is the best-known naturally occurring alkaloid in traditional kratom.

The analytical table reports 0.08mg/g, which calculates to approximately 0.041mg per tablet using the laboratory’s listed tablet weight.

This is a relatively small amount compared with the speciogynine content, meaning the tested sample is more accurately described as speciogynine-dominant than high-mitragynine.

Speciociliatine — 0.07mg/g

Speciociliatine is another naturally occurring stereoisomer of mitragynine found in kratom.

The reported concentration calculates to approximately 0.036mg per tablet. It appears as a minor component of the overall alkaloid profile.

7-Hydroxymitragynine — Not Detected

The laboratory reported 7-hydroxymitragynine as not detected.

The COA states that its detection limit for 7-OH is 0.1ppm. “Not detected” therefore means the amount was below that analytical limit, rather than proving absolute zero under every possible testing method.

Mitragynine Pseudoindoxyl — Not Detected

Mitragynine pseudoindoxyl was also reported as not detected in the tested sample.

This supports positioning Acend as a full-spectrum botanical extract rather than a pseudoindoxyl-enhanced or isolated high-potency tablet.

What Makes Acend Different?

Acend is designed for kratom consumers who prefer:

A broader botanical alkaloid profile
No detected 7-OH or pseudoindoxyl
A scored tablet for controlled portioning
A convenient alternative to powders and liquids
A formula that is not centered around one isolated alkaloid

The dominant speciogynine profile makes this product meaningfully different from standard high-mitragynine extracts and modern 7-OH tablets.

Available Counts

Acend Kratom Extract Tablets may be available in:

4-count
10-count
20-count
50-count
100-count

Available package sizes may vary based on current inventory.

How to Use

Follow the current directions printed on the product packaging.

The manufacturer identifies approximately one quarter of a tablet as a serving. Allow at least 90 minutes before considering any additional amount.

Do not take additional portions simply because the experience is not immediately noticeable. Do not exceed the manufacturer’s labeled serving instructions.

Important Kratom Warning

CONCENTRATED KRATOM EXTRACT — EXPERIENCED ADULT CONSUMERS ONLY.

Kratom contains active botanical alkaloids and may be habit-forming. Frequent use may contribute to tolerance, dependence, or withdrawal symptoms.

Do not combine with alcohol, opioids, benzodiazepines, sedatives, sleep medications, or other substances that may cause impairment or respiratory depression.

Do not drive, operate machinery, or perform dangerous activities after use. Consult a qualified healthcare professional before use if you take medication or have a medical condition.

Do not use while pregnant or nursing. For adults 21 years of age or older only. Keep securely stored and completely out of reach of children and pets.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.